Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.55 is 13% above its 5-year average of 4.91, around the middle of its 5-year range (2.39–12.15).
As of the fiscal period ended Tuesday, June 30, 2026. 35.75% above its 12-month average of 4.09.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.55.
QUICK RATIO (ACID-TEST)
5.55
QUICK RATIO (ACID-TEST) AVG TTM
4.09
QUICK RATIO (ACID-TEST) AVG 3Y
3.93
QUICK RATIO (ACID-TEST) AVG 5Y
4.91
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+35.75%
CURRENT VS 3Y AVG
+41.26%
CURRENT VS 5Y AVG
+12.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
+85.72%
vs the sector median at left
Cardiol Therapeutics Inc.
Market Cap
$151.58M
Quick Ratio (Acid-Test)
5.55
TTM Avg
4.09
3Y Avg
3.93
5Y Avg
4.91
Market Cap
$151.52M
Quick Ratio (Acid-Test)
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$151.60M
Quick Ratio (Acid-Test)
2.99
TTM Avg
3.92
3Y Avg
3.42
5Y Avg
4.30
Market Cap
$153.74M
Quick Ratio (Acid-Test)
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$153.40M
Quick Ratio (Acid-Test)
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$155.86M
Quick Ratio (Acid-Test)
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
Market Cap
$147.97M
Quick Ratio (Acid-Test)
0.84
TTM Avg
0.97
3Y Avg
0.83
5Y Avg
1.00
Market Cap
$146.71M
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiol Therapeutics Inc. (CRDL) | $151.58M | 5.55 | 4.09 | 3.93 | 4.91 |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.52M | 15.62 | 10.23 | 11.93 | 11.24 |
| Codexis, Inc. (CDXS)vs › | $151.60M | 2.99 | 3.92 | 3.42 | 4.30 |
| Minerva Neurosciences, Inc. (NERV)vs › | $153.74M | 20.14 | 22.07 | 21.46 | 19.43 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $153.40M | 9.71 | 4.67 | 6.04 | 19.74 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | 0.45 | 0.24 | 0.20 | 0.38 |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | 0.84 | 0.97 | 0.83 | 1.00 |
| Inogen, Inc. (INGN)vs › | $156.63M | 2.34 | 2.40 | 2.87 | 3.55 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $146.71M | 1.23 | 1.14 | 1.35 | 4.96 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.26M | 2.47 | 5.26 | 13.15 | 16.36 |
Quick Ratio
5.55
Excludes inventory
Current Ratio
5.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.55 |
| 2026-03-31 | 4.39 |
| 2025-12-31 | 4.16 |
| 2025-09-30 | 3.89 |
| 2025-06-30 | 2.46 |
| 2025-03-31 | 3.26 |
| 2024-12-31 | 4.52 |
| 2024-09-30 | 2.49 |
| 2024-06-30 | 2.39 |
| 2024-03-31 | 2.81 |
| 2023-12-31 | 4.36 |
| 2023-09-30 | 5.29 |
| 2023-06-30 | 5.54 |
| 2023-03-31 | 7.32 |
| 2022-12-31 | 6.27 |
| 2022-09-30 | 6.99 |
| 2022-06-30 | 6.45 |
| 2022-03-31 | 7.72 |
| 2021-12-31 | 7.53 |
| 2021-09-30 | 11.90 |
| 2021-06-30 | 12.15 |
| 2021-03-31 | 7.30 |
| 2020-12-31 | 5.80 |
| 2020-09-30 | 9.33 |
| 2020-06-30 | 17.10 |
| 2020-03-31 | 8.65 |
| 2019-12-31 | 11.83 |
| 2019-09-30 | 10.65 |
| 2019-06-30 | 23.11 |
| 2019-03-31 | 20.01 |
| 2018-12-31 | 8.26 |
| 2018-09-30 | 3.36 |
| 2018-06-30 | 9.81 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 14.06 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
